Metraipolis › archive › dc_cf87501a9bf1
Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer — Europe PMC PMID:42165281
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42165281
- DOI
- 10.1002/cam4.71704
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T22:04:43.733Z
- SHA-256 of the archived text
f77045935440339417cf93dfd0373da266b8360049ee38ccf599fc4146cc4974- Stable URL of this page
https://metraipolis.com/documento/dc_cf87501a9bf1
How to cite
Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer — Europe PMC PMID:42165281 — Europe PMC (en), https://europepmc.org/article/MED/42165281 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf87501a9bf1 (Metraipolis archive dc_cf87501a9bf1, sha256 f77045935440339417cf93dfd0373da266b8360049ee38ccf599fc4146cc4974)
BibTeX
@misc{dccf87501a9bf1,
title = {Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer — Europe PMC PMID:42165281},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42165281},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf87501a9bf1; sha256 f77045935440339417cf93dfd0373da266b8360049ee38ccf599fc4146cc4974},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42165281. Agents can read the archived copy with the MCP tool read_document.